本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。给阿基米德一个支点,他就能撬起整个地球。德琪医药恰是学到了阿基米德的精髓,在AI技术如日中天的当下,给市场送出了“转型AI”的支点,换来的则是股价一度超500%的爆发上涨。AI技术最终能否顺利落地尚未可知,但被市场长期看衰的德琪医药,却已经通过“AI概念”实现股价层面的逆天改命。不过,制药行业多年的发展历程证明,热点从来都无法改变...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.